These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15189029)

  • 1. Per-6-substituted-per-6-deoxy beta-cyclodextrins inhibit the formation of beta-amyloid peptide derived soluble oligomers.
    Wang Z; Chang L; Klein WL; Thatcher GR; Venton DL
    J Med Chem; 2004 Jun; 47(13):3329-33. PubMed ID: 15189029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta-peptide oligomerization in silico: dimer and trimer.
    Jang S; Shin S
    J Phys Chem B; 2006 Feb; 110(5):1955-8. PubMed ID: 16471767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interface peptide of Alzheimer's amyloid beta: application in purification.
    Das U; Hariprasad G; Pasha S; Mann A; Ganguli M; Sharma S; Kaur P; Singh TP; Srinivasan A
    Biochem Biophys Res Commun; 2007 Oct; 362(2):538-42. PubMed ID: 17707778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of a soluble amyloid beta-peptide oligomer.
    Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
    Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
    Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
    Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B interactions with soluble oligomers of amyloid Abeta1-42 peptide.
    Smith NW; Annunziata O; Dzyuba SV
    Bioorg Med Chem; 2009 Mar; 17(6):2366-70. PubMed ID: 19268601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Sheet ligands in action: KLVFF recognition by aminopyrazole hybrid receptors in water.
    Rzepecki P; Schrader T
    J Am Chem Soc; 2005 Mar; 127(9):3016-25. PubMed ID: 15740139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.
    Karr JW; Kaupp LJ; Szalai VA
    J Am Chem Soc; 2004 Oct; 126(41):13534-8. PubMed ID: 15479110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers.
    Yu J; Bakhos L; Chang L; Holterman MJ; Klein WL; Venton DL
    J Mol Neurosci; 2002; 19(1-2):51-5. PubMed ID: 12212793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
    Rauk A
    Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
    Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
    Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.